Brochure
3 Nov 2022
Elevator Pitch
PPTX
HFM is
a Californian-Swiss
Biotech
company developing new drugs
in virology, immunology
and
oncology
with
a focus
on COVID-19
since December 2019.
Acute and even more Chronic Covid continue to remain major challenges.
There are a few drugs on the market which are however not being used widely due to lack of efficacy
and difficult challenges in prescriptions. Also
vaccines are not the solution for various reasons.
We have developed two drugs against
acute and chronic Covid- 19, preventive as well as for
treatment, ready for market entry in
Q4 -2022.
Content provided by our supplier
Hybrid Fusion Medicals - HFM AG
-
CH -
2022On CPHI since
-
1 - 24Employees
Company types
Primary activities
Other Content from Hybrid Fusion Medicals - HFM AG ()
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance